301089 拓新药业
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--01,4511,4511,051
投资性房地产0--0000
固定资产488,043-1.88%497,386478,348479,786413,520
在建工程378,4551.55%372,682331,031130,47735,589
无形资产81,129-0.85%81,82784,04284,26184,561
商誉0--0000
其他非流动资产133,0572.88%129,337121,952133,27462,233
1,080,684-0.05%1,081,2321,016,825829,250596,953

流动资产
货币资金151,136118.30%69,234148,554307,092284,196
应收账款89,76914.23%78,588151,67842,04257,415
存货196,1859.67%178,883204,111241,139167,083
其他流动资产233,919-33.22%350,307317,827423,733288,064
671,009-0.89%677,012822,1701,014,006796,759

流动负债
短期借款0--0040,03464,500
应付票据35,5693.48%34,37242,16059,08267,621
应付帐款97,385-1.47%98,835110,38999,49895,317
其他流动负债29,322-8.70%32,11741,964225,35027,160
162,275-1.84%165,325194,512423,963254,597
流动资产净值508,734-0.58%511,688627,658590,042542,161
资产总额减流动负债1,589,418-0.22%1,592,9191,644,4821,419,2921,139,114

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债40,4630.16%40,39941,21042,92341,754
40,4630.16%40,39941,21042,92341,754

总权益
    实收股本126,5450.00%126,545126,545126,000126,000
    储备项目1,422,411-0.25%1,425,9761,476,7271,250,370971,360
股东权益1,548,955-0.23%1,552,5201,603,2721,376,3701,097,360
非控股权益0--0000